fifteen patients ( six patients with adenocarcinoma , seven patients with squamous cell carcinoma , and two patients with large cell carcinoma ) with advanced non-small cell lung cancer ( nsclc ) were evaluable for mitomycin c ( mmc ; 8 mg/m2 day 1 , 8 , every 3-4 weeks ) plus cisplatin ( cddp ; 80 mg/m2 day 1 , every 3-4 weeks ) .
C0001418
adenocarcinoma
C0002475
mmc